Health-related quality of life in patients with locally advanced or metastatic breast cancer treated with eribulin mesylate or capecitabine in an open-label randomized phase 3 trial
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Health-related quality of life in patients with locally advanced or metastatic breast cancer treated with eribulin mesylate or capecitabine in an open-label randomized phase 3 trial
Authors
Keywords
Breast cancer, Eribulin, Quality of life, Minimally important difference, Side effects
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 154, Issue 3, Pages 509-520
Publisher
Springer Nature
Online
2015-11-14
DOI
10.1007/s10549-015-3633-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 1046PIMPACT OF TREATMENT WITH ERIBULIN (ERI) OR CAPECITABINE (CAP) FOR METASTATIC BREAST CANCER (MBC) ON EQ–5D UTILITY DERIVED FROM EORTC QLQ–C30
- (2017) S. Hudgens et al. ANNALS OF ONCOLOGY
- Effects of Second and Subsequent Lines of Chemotherapy for Metastatic Breast Cancer
- (2015) In Hae Park et al. Clinical Breast Cancer
- Symptomatic Toxicities Experienced During Anticancer Treatment: Agreement Between Patient and Physician Reporting in Three Randomized Trials
- (2015) Massimo Di Maio et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Open-Label Randomized Study of Eribulin Mesylate Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane
- (2015) Peter A. Kaufman et al. JOURNAL OF CLINICAL ONCOLOGY
- Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
- (2014) E. Basch et al. JNCI-Journal of the National Cancer Institute
- Quality of Life under Capecitabine (Xeloda®) in Patients with Metastatic Breast Cancer: Data from a German Non-Interventional Surveillance Study
- (2014) Volkmar Müller et al. Oncology Research and Treatment
- Health-related quality of life and symptoms in patients with myelofibrosis treated with ruxolitinibversusbest available therapy
- (2013) Claire N. Harrison et al. BRITISH JOURNAL OF HAEMATOLOGY
- Capecitabine Monotherapy: Review of Studies in First-Line HER-2-Negative Metastatic Breast Cancer
- (2012) J. A. O'Shaughnessy et al. ONCOLOGIST
- Randomized phase II non-inferiority study (NO16853) of two different doses of capecitabine in combination with docetaxel for locally advanced/metastatic breast cancer
- (2011) A. U. Buzdar et al. ANNALS OF ONCOLOGY
- Meta-analysis of phase III trials of docetaxel alone or in combination with chemotherapy in metastatic breast cancer
- (2011) Maurizio Belfiglio et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Quality of Life and Experience of Care in Women With Metastatic Breast Cancer: A Cross-Sectional Survey
- (2011) Elizabeth Reed et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Assessing the Quality and Value of Quality-of-Life Measurement in Breast Cancer Clinical Trials
- (2011) Patricia A. Ganz JNCI-Journal of the National Cancer Institute
- Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study
- (2011) Javier Cortes et al. LANCET
- Health-related quality of life and cancer clinical trials
- (2011) David Osoba Therapeutic Advances in Medical Oncology
- Randomized Phase III Trial of Ixabepilone Plus Capecitabine Versus Capecitabine in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane
- (2010) Joseph A. Sparano et al. JOURNAL OF CLINICAL ONCOLOGY
- Evidence-Based Guidelines for Determination of Sample Size and Interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30
- (2010) Kim Cocks et al. JOURNAL OF CLINICAL ONCOLOGY
- The Missing Voice of Patients in Drug-Safety Reporting
- (2010) Ethan Basch NEW ENGLAND JOURNAL OF MEDICINE
- Review: Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management
- (2009) Alexander Stein et al. Therapeutic Advances in Medical Oncology
- Metastatic Breast Cancer: The Treatment Challenge
- (2008) Stephen E. Jones Clinical Breast Cancer
- Chemotherapy and cancer related nausea and vomiting
- (2008) David Warr Current Oncology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started